Short answer
ARROW FINANCIAL CORP (AROW) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026.
ARROW FINANCIAL CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Unaudited financial information and management discussion furnished in Exhibit 99.1
- Investor focus: operating performance details require review of the attached earnings release
Item 7.01 · Regulation FD Disclosure
- Second-quarter 2026 investor presentation released July 23, 2026
- Covers financial results and trends through June 30, 2026
- Presentation should be reviewed with the June 30, 2026 earnings release
- Exhibit 99.2 provides the substantive investor materials and is furnished, not filed under Section 18 liability rules
Item 8.01 · Other Events
- Quarterly cash dividend declared at $0.30 per share
- Payable August 25, 2026 to shareholders of record August 11, 2026
- Dividend declaration signals continued shareholder-return commitment
Item EX-99.1 · Exhibit EX-99.1
- Q2 net income $11.0M, EPS $0.66, down from $13.5M and $0.82 in Q1
- Adjusted EPS $0.71 after $1.0M of merger expenses tied to Adirondack acquisition
- Adirondack acquisition added approximately $1.0B in assets and 19 branches, with significant EPS accretion expected in 2027 and beyond
- Credit risk increased: $3.8M commercial loan became non-performing, requiring a $1.6M specific reserve
- Loans grew $57.6M, while deposits fell $358.7M and borrowings rose to $310.2M
- Quarterly dividend maintained at $0.30 per share, payable August 25, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ARROW FINANCIAL CORP 8-K filings
Get the next AROW 8-K as it lands
Follow AROW for push alerts, or ask the research agent what this filing means.